The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer-Reference-Cited by-同舟云学术

The updated network meta-analysis of neoadjuvant therapy for HER2-positive breast cancer

Published:2018-01 Issue: Volume:62 Page:9-17
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Nakashoji Ayako,Hayashida Tetsu,Yokoe Takamichi,Maeda Hinako,Toyota Tomoka,Kikuchi Masayuki,Watanuki Rurina,Nagayama Aiko,Seki Tomoko,Takahashi Maiko,Abe Takayuki,Kitagawa Yuko

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference39 articles.

1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001

2. Neoadjuvant and adjuvant therapy for HER2 positive disease;Chia;Am Soc Clin Oncol Educ Book,2015

3. Network NCC. NCCN Clinical Practice Guidelines in Oncolgy (NCCN Guidelines) Breast Cancer NCCN Evidence Blocks (Version 2. 2017).

4. Lapatinib: a dual inhibitor of EGFR and HER2 tyrosine kinase activity;Montemurro;Expert Opin Biol Ther,2007

5. HER2-directed therapy: current treatment options for HER2-positive breast cancer;Ahmed;Breast Cancer,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-utility and budget impact analysis of neoadjuvant dual HER2 targeted therapy for HER2-positive breast cancer in Sri Lanka;Scientific Reports;2024-07-20

2. Respuesta patológica completa de pacientes con cáncer de mama HER2 positivo tratadas con quimioterapia neoadyuvante en Colombia;Biomédica;2023-09-30

3. Predictors of successful neoadjuvant treatment in HER2‑positive breast cancer;Oncology Letters;2023-08-22

4. Determining the Optimal (Neo)Adjuvant Regimen for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Regarding Survival Outcome: A Network Meta-Analysis;Frontiers in Immunology;2022-06-30

5. A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles;Breast Cancer Research and Treatment;2022-02-28